Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xulu Yang

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 1, 2026
Prophylactic sequential drug administration potentiates cancer radiotherapy by inhibiting cholesterol deposition and cellular senescenceShanshan Lang, Xulu Yang, Xin Zhao, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 2, 2026
Emerging Biomaterials Blocking PD-1/PD-L1 Pathway for Cancer TherapyYi Zhu, Jiawei Song, Yansheng Zhu, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 10, 2026
Reprogramming Tumor-Associated Neutrophils to Enhance Radio-ImmunotherapyXulu Yang, Shanshan Lang, Tongtong Liu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 3, 2024
Engineered bacteria breach tumor physical barriers to enhance radio-immunotherapyYanxiang Zhang, Yue Liu, Tingting Li, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 1, 2025
Reprogramming of radiation-deteriorated TME by liposomal nanomedicine to potentiate radio-immunotherapyYue Liu, Yanxiang Zhang, Xulu Yang, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 1, 2026
Prophylactic sequential drug administration potentiates cancer radiotherapy by inhibiting cholesterol deposition and cellular senescenceShanshan Lang, Xulu Yang, Xin Zhao, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 2, 2026
Emerging Biomaterials Blocking PD-1/PD-L1 Pathway for Cancer TherapyYi Zhu, Jiawei Song, Yansheng Zhu, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 10, 2026
Reprogramming Tumor-Associated Neutrophils to Enhance Radio-ImmunotherapyXulu Yang, Shanshan Lang, Tongtong Liu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 3, 2024
Engineered bacteria breach tumor physical barriers to enhance radio-immunotherapyYanxiang Zhang, Yue Liu, Tingting Li, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 1, 2025
Reprogramming of radiation-deteriorated TME by liposomal nanomedicine to potentiate radio-immunotherapyYue Liu, Yanxiang Zhang, Xulu Yang, et al.
Pageof 1